Enoxaparin sodium: all 35 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Lovenox With Aspirin in Thawed Blastocyst TransferRecruitingNCT06133803Phase 4
- Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot ProjectRecruitingNCT06004674Phase 2
- THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingNCT05735639Phase 4
- Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)RecruitingNCT04861103Phase 4
- Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)RecruitingNCT02342444Phase 4
- Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19CompletedNCT04367831Phase 4Results posted
- COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) TrialCompletedNCT04354155Phase 2Results posted
- A Different Approach to Preventing ThrombosisCompletedNCT02774265Phase 3Results posted
- Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.CompletedNCT02232802Phase 1Results posted
- A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting ConditionsCompletedNCT02081950Phase 1Results posted
- Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill PatientsTerminatedNCT00521885Not applicableResults posted
- Comparison of Visual Outcomes of Pars Plana Vitrectomy With and Without Injection Clexane for Rhegmatogenous Retinal Detachment Proliferative VitreoretinopathyActive, not recruitingNCT07787377Not applicable
- Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS PatientsCompletedNCT06114641Phase 4
- Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human SubjectsCompletedNCT05265676Phase 1
- Enoxaparin Bioequivalence Study in Acute Coronary Syndrome PatientsCompletedNCT04552067Phase 1
- Concentration-effect Relationship of Enoxaparin for Thromboembolic PreventionWithdrawnNCT04520620Phase 4
- Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs RivaroxabanStatus unknownNCT04169269Phase 4
- Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy VolunteersCompletedNCT03363477Phase 1
- Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal CancerStatus unknownNCT03254511Phase 2
- Timing of VTE Prophylaxis in TBIWithdrawnNCT03081169Phase 4
- Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery PatientsCompletedNCT02687204Phase 1
- Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI)CompletedNCT02325479Phase 1
- Enoxamed Study in the Treatment of Acute Coronary SyndromesCompletedNCT02152423Phase 1
- Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary SyndromeCompletedNCT01687491Phase 4
- Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal SurgeryCompletedNCT01308528Phase 3
- Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe PreeclampsiaCompletedNCT00986765Phase 3
- Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual AbortionCompletedNCT00959621Phase 3
- A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)WithdrawnNCT00916669Phase 2
- Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)CompletedNCT00349180Phase 3
- The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.TerminatedNCT00232271Phase 4
- Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)CompletedNCT00077844Phase 2/3
- Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)CompletedNCT00077818Phase 4
- PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)CompletedNCT00077805Phase 4
- Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)CompletedNCT00077792Phase 3
- EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged ImmobilizationCompletedNCT00077753Phase 4